KNAPP will present its range of solutions for the sector on its stand (F20) at The Pharmacy Show, which takes place on 12-13th October at the NEC in Birmingham.
Nemera relies on Mitutoyo measurement and inspection solutions to ensure its health-critical dispensers, inhalers and pens deliver the exact specified amount of active ingredient.
Michael Franco, director of Global Biopharma Sales, PSG Biotech explores the question: "how do we maintain the benefits of single-use while reducing the environmental burden they create?"
The Hosokawa Micron Group and its subsidiaries will be presenting their range of products and services in Hall 11, Stand 137 at Powtech Technopharm 2025 in Nuremberg from 23 - 25th September.
Asymchem, a company in contract development and manufacturing (CDMO) solutions, has announced an expansion of its flow chemistry capabilities at its Sandwich, UK facility.
The UK’s new industrial strategy has been welcomed by the Institution of Chemical Engineers (IChemE), though it warns more clarity is needed to ensure lasting benefits. Duncan Lugton, head of Policy & Impact, analyses the plan.
Fraunhofer IPA and the Natural and Medical Sciences Institute at the University of Tübingen investigated the material compatibility of the dry quattroClean snow jet cleaning technology on product surfaces typically found in the pharma sector.
Vicki Pearson, strategic marketing manager at Schneider Electric, discusses how modern environmental monitoring and compliance systems help life sciences firms meet regulatory demands while improving efficiency and security.
Glatt Ingenieurtechnik will be presenting integrated concepts combining particle design, process expertise, process and plant engineering and factory planning at POWTECH TECHNOPHARM in Nuremberg from 23 - 25th September 2025.
In this article, Jim Donovan, general manager for Pfizer CentreOne, explores the concept of “lightspeed” development under high-pressure situations, such as pandemics and drug shortages.
Indero explore how Lean Six Sigma (LSS) principles are being adapted from manufacturing industries to deliver clinical trials faster, more efficiently, and with greater consistency.
Santhera signs an agreement with Uniphar to manage the distribution of AGAMREE (vamorolone) in the United Arab Emirates, the Kingdom of Saudi Arabia, Kuwait, Oman and Bahrain, for the treatment of Duchenne muscular dystrophy (DMD).
